ClinicalTrials.Veeva

Menu

Group Exercise Program Supported By Audiovisual Media During Hemodialysis (GrExID)

C

Cardenal Herrera University

Status

Active, not recruiting

Conditions

Chronic Kidney Failure
Functional Capacity
Hemodialysis
Muscle Strength Dynamometer
Physical Activity Level
Sarcopenia

Treatments

Other: Exercise program supported by audiovisual media

Study type

Interventional

Funder types

Other
Industry

Identifiers

Details and patient eligibility

About

People with chronic kidney disease (CKD) undergoing hemodialysis (HD) experience muscular complications, such as sarcopenia, which worsen their functional capacity and increase mortality. Exercise programs during HD are an effective strategy to combat sedentary behavior, and implementing them through innovative technologies could facilitate their adoption in clinics, benefiting more patients. Therefore, the study's objectives are to assess the feasibility and safety of a group exercise program supported by audiovisual media conducted during HD sessions. Additionally, it will analyze factors influencing adherence, identify potential causes for interruptions or failure to perform the prescribed exercise, and evaluate the risk and prevalence of sarcopenia, its association with low muscle strength, poor muscle quality, and physical inactivity.

Full description

A 4-week randomized experimental study will be conducted, using an exercise protocol during HD, broadcast simultaneously on television. The frequency of exercise completion, reasons for non-completion, adverse events, as well as sarcopenia, muscle strength, muscle characteristics through ultrasound and electrical bioimpedance, and physical activity levels will be evaluated.

Enrollment

45 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Over 18 years old of both sexes;
  • Undergoing HD for at least three months in three sessions per week, four hours, totaling 12 hours per week.

Exclusion criteria

  • Lower limb amputations;
  • Neurological, musculoskeletal, or osteoarticular disorders;
  • Severe and unstable comorbidities;
  • Undergoing high doses of corticosteroids (>30 mg/day);
  • Inability to understand the measurement methods used.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

45 participants in 2 patient groups

Intervention Group (IG)
Experimental group
Description:
Patients over 18 years old of both sexes, who have been undergoing HD for at least three months, generally in three sessions per week that are in the room that was randomized to do exercise.
Treatment:
Other: Exercise program supported by audiovisual media
Control Group (CG)
No Intervention group
Description:
Patients over 18 years old of both sexes, who have been undergoing HD for at least three months, generally in three sessions per week that are in the room that was randomized to will continue with the usual treatment.

Trial contacts and locations

1

Loading...

Central trial contact

Emanuele G Emanuele Gravina, Msc; Eva S Segura-Orti, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems